Atıf Formatları
Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. Yorgancloǧlu Et Al. , "Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial," INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.176, no.3-4, 2018

Yorgancloǧlu, A. Et Al. 2018. Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.176, no.3-4 .

Yorgancloǧlu, A., Erkekol, F. Ö., MUNGAN, V. D., Erdinç, M., GEMİCİOĞLU, B., Özşeker, Z. F., ... Bayrak Deǧirmenci, P.(2018). Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.176, no.3-4.

Yorgancloǧlu, Arzu Et Al. "Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial," INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.176, no.3-4, 2018

Yorgancloǧlu, Arzu Et Al. "Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial." INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.176, no.3-4, 2018

Yorgancloǧlu, A. Et Al. (2018) . "Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial." INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.176, no.3-4.

@article{article, author={Arzu Yorgancloǧlu Et Al. }, title={Long-Term Omalizumab Treatment: A Multicenter, Real-Life, 5-Year Trial}, journal={INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY}, year=2018}